A whistleblower by the name of Crystal Derrick informed federal agencies that Roche Diagnostics overpaid Humana $45 million in drug rebates. Derrick's testimony also suggested that Roche Diagnostics offered to accept a $27.5 million of the $45 million and would allow Humana to keep the remainder.
Blog
Almost a decade after Bernard Madoff's Ponzi scheme collapsed, the trustee unwinding his fraud struck another settlement with one of the con man's earliest investors -- a $280 million deal with the hedge-fund operator and philanthropist J. Ezra Merkin.
A federal appeals court on Monday revived a whistleblower lawsuit accusing Brookdale Senior Living Inc of submitting claims to Medicare for home health services even though doctors failed to timely certify that patients were eligible to receive them.
The Richland-based whistleblower's case finally settled this week, generating more than $5.5 million in fines against the company and a total of $690,000 paid to Savage for alerting the government to the swindle.
Malaysia has issued an arrest warrant for financier Low Taek Jho, wanted for questioning in a graft probe involving former prime minister Najib Razak and state fund 1MDB, a media report and a source familiar with the matter said on Thursday.
The settlement with Allegiance resolves a lawsuit filed in the Eastern District of Arkansas under the whistleblower provision of the False Claims Act, which permits private parties to file suit on behalf of the United States for false claims and share in a portion of the government's recovery.
Whistleblower Christopher Wylie has told the European Parliament that the influence of Cambridge Analytica on the Brexit referendum has rendered its result illegitimate.
The SEC said these arrangements gave deVere an incentive to provide advice that would lead to the payments, resulting in undisclosed compensation of $2.6 million for Alderson and $2.1 million for Hamilton.
Mercy Health settles what's called a False Claims Act, which fines companies, often in healthcare or pharmaceutical fields, for defrauding governmental programs.
The U.S. has opened a criminal investigation into whether traders manipulated prices in the $550 billion market for unsecured bonds issued by Fannie Mae and Freddie Mac, according to people familiar with the matter.
The lawsuit was brought under the qui tam, or whistleblower, provisions of the False Claims Act by three former employees of Inchcape.
The judgment follows the January 31, 2018, jury verdict finding the three individuals liable for violating the False Claims Act (FCA) by paying remuneration to physicians in exchange for patient referrals, in violation of the Anti-Kickback Statute, and causing two laboratories to bill federal health care programs for medically unnecessary testing.
A federal jury found a physician guilty today for her role in a scheme involving approximately $8.9 million in fraudulent Medicare claims for home health care and other physician services that were procured through the payment of kickbacks, were not medically necessary, not actually provided or, in some cases, were provided by the defendant, who was not a licensed physician during the conspiracy.
Pfizer Inc agreed to pay $23.85 million to resolve U.S. charges that it used a purportedly independent charity to pay illegal kickbacks to Medicare patients, covering their out-of-pocket costs for its prescription drugs.
Cambridge Analytica whistle-blower Christopher Wylie said Facebook Inc. Chief Executive Officer Mark Zuckerberg engaged in "a spectacle of non-answers" in testimony before U.S. and European lawmakers that would increase the chances the social network will face regulation and further harm the trust of its users.
The scheme is alleged to have resulted a loss of up to $1.8 million to the Medicare program by submitting claims to Medicare from 2013 through 2017 related to Medicare beneficiary information that he obtained by paying illegal kickbacks.
A former Valeant Pharmaceuticals International Inc. executive was found guilty of accepting a $10 million bribe for manipulating the company's takeover of a startup mail-order pharmacy in 2014 -- the latest fallout from a scandal that shook the drugmaker.
GlaxoSmithKline is facing fresh criticism over the way it treats whistleblowers after a lawsuit was filed by a former senior technical lead claiming he was harassed and wrongfully dismissed after repeatedly warning over issues with the pharmaceutical giant's computer fleet.
The Justice Department and the Virginia attorney general's office are jumping in to a whistleblower's lawsuit alleging a subcontractor deliberately used bad concrete on a $2.6 billion project to extend the D.C. region's Metrorail system to Dulles International Airport.
The Securities and Exchange Commission is pitching a fake initial coin offering to educate investors on the pitfalls of too-good-to-be-true ventures. The bogus digital currency, called HoweyCoins, has a sleek website, complete with a white paper, and pictures of made-up celebrity promoters and luxurious destinations. The token's backers anticipate at least 1 percent daily returns and a hedge against inflation by combining "the magic of coin trading profits and the excitement and guaranteed returns of the travel industry.
